1. Home
  2. FTRE vs QNST Comparison

FTRE vs QNST Comparison

Compare FTRE & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • QNST
  • Stock Information
  • Founded
  • FTRE 1996
  • QNST 1999
  • Country
  • FTRE United States
  • QNST United States
  • Employees
  • FTRE N/A
  • QNST N/A
  • Industry
  • FTRE Medical Specialities
  • QNST Business Services
  • Sector
  • FTRE Health Care
  • QNST Consumer Discretionary
  • Exchange
  • FTRE Nasdaq
  • QNST Nasdaq
  • Market Cap
  • FTRE 864.4M
  • QNST 923.2M
  • IPO Year
  • FTRE N/A
  • QNST 2010
  • Fundamental
  • Price
  • FTRE $9.88
  • QNST $13.53
  • Analyst Decision
  • FTRE Hold
  • QNST Buy
  • Analyst Count
  • FTRE 9
  • QNST 5
  • Target Price
  • FTRE $13.31
  • QNST $26.40
  • AVG Volume (30 Days)
  • FTRE 1.4M
  • QNST 596.6K
  • Earning Date
  • FTRE 11-05-2025
  • QNST 11-06-2025
  • Dividend Yield
  • FTRE N/A
  • QNST N/A
  • EPS Growth
  • FTRE N/A
  • QNST N/A
  • EPS
  • FTRE N/A
  • QNST 0.18
  • Revenue
  • FTRE $2,759,900,000.00
  • QNST $1,100,345,000.00
  • Revenue This Year
  • FTRE $0.47
  • QNST $11.18
  • Revenue Next Year
  • FTRE N/A
  • QNST $9.54
  • P/E Ratio
  • FTRE N/A
  • QNST $76.26
  • Revenue Growth
  • FTRE 1.88
  • QNST 43.12
  • 52 Week Low
  • FTRE $3.97
  • QNST $13.43
  • 52 Week High
  • FTRE $25.05
  • QNST $25.50
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 45.63
  • QNST 37.04
  • Support Level
  • FTRE $10.89
  • QNST $13.53
  • Resistance Level
  • FTRE $12.07
  • QNST $14.56
  • Average True Range (ATR)
  • FTRE 0.97
  • QNST 0.63
  • MACD
  • FTRE -0.13
  • QNST -0.05
  • Stochastic Oscillator
  • FTRE 10.15
  • QNST 0.22

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

About QNST QuinStreet Inc.

QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia.

Share on Social Networks: